• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于化学生物学的方法实现 IgG 型抗体-寡核苷酸偶联物的精确结构控制。

Chemical Biology Approaches toward Precise Structure Control of IgG-Based Antibody-Oligonucleotide Conjugates.

机构信息

Institute of Chemical Biology and Nanomedicine, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan Provincial Key Laboratory of Biomacromolecular Chemical Biology, School of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan, 410082, P. R. China.

出版信息

Chembiochem. 2023 May 2;24(9):e202300077. doi: 10.1002/cbic.202300077. Epub 2023 Mar 30.

DOI:10.1002/cbic.202300077
PMID:36892014
Abstract

Antibody-oligonucleotide conjugates (AOCs) are important tools for drug development and biochemical analysis. However, the structural heterogeneity of AOCs synthesized through conventional coupling methods raises reproducibility and safety concerns in clinical trials. To address these issues, different covalent coupling approaches have been developed to synthesize AOCs with precise site-specificity and degree of conjugation. This Concept article categorizes these approaches as linker-free or linker-mediated and provides details on their chemistry and potential applications. Several factors, including site-specificity, conjugation control, accessibility, stability, and efficiency, are highlighted when evaluating the pros and cons of these approaches. The article also discusses the future of AOCs, including the development of better conjugation approaches to ensure stimuli-responsive release and the application of high-throughput methods to facilitate their development.

摘要

抗体-寡核苷酸偶联物 (AOCs) 是药物开发和生化分析的重要工具。然而,通过传统偶联方法合成的 AOCs 的结构异质性引起了临床试验中的重现性和安全性问题。为了解决这些问题,已经开发了不同的共价偶联方法来合成具有精确的位点特异性和偶联程度的 AOCs。本文将这些方法归类为无连接子或连接子介导,并详细介绍了它们的化学性质和潜在应用。在评估这些方法的优缺点时,突出了几个因素,包括位点特异性、偶联控制、可及性、稳定性和效率。本文还讨论了 AOCs 的未来,包括开发更好的偶联方法以确保刺激响应性释放,以及应用高通量方法来促进其发展。

相似文献

1
Chemical Biology Approaches toward Precise Structure Control of IgG-Based Antibody-Oligonucleotide Conjugates.基于化学生物学的方法实现 IgG 型抗体-寡核苷酸偶联物的精确结构控制。
Chembiochem. 2023 May 2;24(9):e202300077. doi: 10.1002/cbic.202300077. Epub 2023 Mar 30.
2
Development of a Versatile and Modular Linker for Antibody-Drug Conjugates Based on Oligonucleotide Strand Pairing.基于寡核苷酸链配对的用于抗体-药物偶联物的通用模块化连接子的开发
Bioconjug Chem. 2020 Jul 15;31(7):1804-1811. doi: 10.1021/acs.bioconjchem.0c00281. Epub 2020 Jun 25.
3
Antibody-Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents.抗体-寡核苷酸缀合物作为治疗、成像和检测试剂。
Bioconjug Chem. 2019 Oct 16;30(10):2483-2501. doi: 10.1021/acs.bioconjchem.9b00306. Epub 2019 Jul 24.
4
Site Selective Antibody-Oligonucleotide Conjugation via Microbial Transglutaminase.通过微生物转谷氨酰胺酶实现抗体-寡核苷酸的定点偶联。
Molecules. 2019 Sep 10;24(18):3287. doi: 10.3390/molecules24183287.
5
Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates.固相位点特异性缀合的发展及其在双标记抗体和Fab药物缀合物生成中的应用。
Bioconjug Chem. 2016 Apr 20;27(4):1030-9. doi: 10.1021/acs.bioconjchem.6b00054. Epub 2016 Mar 22.
6
High-Throughput Platform to Identify Antibody Conjugation Sites from Antibody-Drug Conjugate Libraries.从抗体药物偶联物库中鉴定抗体偶联位点的高通量平台。
Bioconjug Chem. 2020 Apr 15;31(4):1199-1208. doi: 10.1021/acs.bioconjchem.0c00146. Epub 2020 Mar 27.
7
A Concise, Modular Antibody-Oligonucleotide Conjugation Strategy Based on Disuccinimidyl Ester Activation Chemistry.基于双琥珀酰亚胺酯活化化学的简洁、模块化抗体-寡核苷酸偶联策略。
Chembiochem. 2019 Jun 14;20(12):1599-1605. doi: 10.1002/cbic.201900027. Epub 2019 May 3.
8
Bioanalytical approaches to support the development of antibody-oligonucleotide conjugate (AOC) therapeutic proteins.支持抗体-寡核苷酸偶联物(AOC)治疗性蛋白质开发的生物分析方法。
Xenobiotica. 2024 Aug;54(8):552-562. doi: 10.1080/00498254.2024.2339983. Epub 2024 Sep 27.
9
Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.近期用于天然抗体定点偶联的化学方法:迈向新一代抗体药物偶联物的技术。
Chembiochem. 2019 Nov 4;20(21):2729-2737. doi: 10.1002/cbic.201900178. Epub 2019 Jul 17.
10
Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates.连接子和缀合化学对模型抗体药物偶联物的抗原结合、Fc 受体结合和热稳定性的影响。
MAbs. 2012 May-Jun;4(3):362-72. doi: 10.4161/mabs.19449. Epub 2012 Apr 26.

引用本文的文献

1
Methods for the Generation of Single-Payload Antibody-Drug Conjugates.单有效载荷抗体-药物偶联物的生成方法。
ChemMedChem. 2025 May 19;20(10):e202500132. doi: 10.1002/cmdc.202500132. Epub 2025 Mar 19.
2
Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking.治疗性寡核苷酸:改善内体运输的化学策略展望。
Cells. 2023 Sep 11;12(18):2253. doi: 10.3390/cells12182253.